EUVIMEDEUVIMED entdecken
Crossref

HIF‐1α and PD‐L1 as Predictive Efficacy Markers for Neoadjuvant Chemoradiotherapy in Rectal Cancer

Samir Johna

World Journal of Surgery · 2026-05 · 50 (5) · 1148-1149

DOI: 10.1002/wjs.70353 ↗

Kurz gefasst

Fachartikel in der Zeitschrift World Journal of Surgery, online erschienen am 05.04.2026. Verfasst von Samir Johna. Beteiligte Einrichtung: Bernard Tyson Kaiser Permanente School of Medicine, Pasadena, California, USA. Die Arbeit nennt 6 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Bernard Tyson Kaiser Permanente School of Medicine, Pasadena, California, USA.
  • Loma Linda University School of Medicine California, Linda, California, USA.

Zitieren

APA

Johna, S. (2026). HIF‐1α and PD‐L1 as Predictive Efficacy Markers for Neoadjuvant Chemoradiotherapy in Rectal Cancer. World Journal of Surgery, 50(5), 1148-1149. https://doi.org/10.1002/wjs.70353

Vancouver

Johna S. HIF‐1α and PD‐L1 as Predictive Efficacy Markers for Neoadjuvant Chemoradiotherapy in Rectal Cancer. World Journal of Surgery. 2026;50(5):1148-1149. doi:10.1002/wjs.70353

BibTeX
@article{Johna2026,
  author = {Johna, Samir},
  title = {HIF‐1α and PD‐L1 as Predictive Efficacy Markers for Neoadjuvant Chemoradiotherapy in Rectal Cancer},
  journal = {World Journal of Surgery},
  year = {2026},
  volume = {50},
  number = {5},
  pages = {1148--1149},
  doi = {10.1002/wjs.70353}
}
Kostenlos starten →